About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Philadelphia | 95 Studies

Clinical Trials COVID-19Philadelphia

COVID-19 Clinical Trials in Philadelphia

Find 95 clinical trials for covid-19 near Philadelphia, Pennsylvania. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-95 of 95 trials

CompletedStudy of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced PneumoniaThis was a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of canakinumab plus standard-of-care (SOC) compared with placebo plus…NCT04362813·Birmingham, Alabama and 38 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy of Efficacy and Safety of MAS825 in Patients With COVID-19This clinical study was designed to assess the efficacy and safety of MAS825 for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infected patients…NCT04382651·Chula Vista, California and 20 others

TerminatedA Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and AdultsThe primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised…NCT05074433·Birmingham, Alabama and 66 others

CompletedNovel Experimental COVID-19 Therapies Affecting Host ResponseThe overarching goal of the Master Protocol is to find effective strategies for inpatient management of patients with COVID-19.NCT04924660·Birmingham, Alabama and 50 others

CompletedThe Prevent Severe COVID-19 (PRESECO) StudyDouble-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19…NCT04600895·Pelham, Alabama and 37 others

CompletedA Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222…NCT05815498·Huntsville, Alabama and 229 others

TerminatedAssessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)The purpose of this study is to evaluate the efficacy and safety of ruxolitinib in the treatment of participants with COVID-19-associated Acute Respiratory Distress Syndrome…NCT04377620·Scottsdale, Arizona and 35 others

CompletedCOVID-19 Screening ProgramIn view of the recent COVID surge and difficulties in obtaining testing, we aim to increase Point of Care (POC) testing, whereby University of Pennsylvania (Penn) faculty, staff…NCT05216627·Philadelphia, Pennsylvania

CompletedMultisite Observational Maternal and Infant Study for COVID-19This is an observational, non-interventional, prospective cohort study designed to collect clinical information and specimens to evaluate the immune responses from pregnant…NCT05031468·Atlanta, Georgia and 9 others

TerminatedReparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired PneumoniaPrimary objective: \- To compare the efficacy of reparixin vs. placebo in the proportion of patients dead or requiring IMV (or ECMO) by Day 28.NCT05254990·Tucson, Arizona and 73 others

CompletedUnderstanding the Long-term Impact of COVID-19 in Adults (RECOVER)This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at…NCT05172024·Birmingham, Alabama and 85 others

CompletedParent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)AZD3152, a single mAb, is being developed to have broad neutralizing activity across known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.NCT05648110·Birmingham, Alabama and 214 others

CompletedCOVID-19 SAFE EnrollmentIn order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage…NCT04506268·Philadelphia, Pennsylvania

Active not recruitingUnderstanding the Long-term Impact of COVID on Children and FamiliesThis is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals age 0-25 years who will enter the cohort with and without SARS-CoV-2…NCT05172011·Birmingham, Alabama and 64 others

CompletedSafety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19The primary objectives are: Pooled Phase 3 (Cohort 1) and Phase 2 (Cohort 1A) * To evaluate the virologic efficacy of REGN10933+REGN10987 compared to placebo in reducing viral…NCT04426695·Birmingham, Alabama and 122 others

PreviousPage 5 of 5

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia